PHARMENA

‍PHARMENA SA is a rapidly growing public biotechnology company. Our main activity is the development and commercialization of innovative products based on the patented active ingredient — 1-MNA.

We focus on areas related to longevity and healthy lifestyles, supporting the natural processes of cell regeneration and maintaining the best possible health into the late years of life.

Company activity involves the marketing of innovative and safe products and the conduct of clinical trials of anti-inflammatory and anti-fibrotic drugs. We work with the leaders of science and technology, in search of innovative and unique solutions to take care of the state of human health in the best possible way.

ENDOTHELIUM — Longevity and Vitality! A recent discovery in the field of supplementation.

The only products on the market containing 1-MNA molecule, optimizing the level of coenzyme NAD+. Backed by international research.